- ViewRay ( NASDAQ: VRAY ) said that the VA Houston Healthcare System has selected a MRIdian MRI-guided radiation therapy system to expand services at the Michael E. DeBakey VA Medical Center.
- The system will enable the VA Houston Cancer Program to offer advanced MRI-guided radiation therapy technology to veterans in the region who are seeking personalized treatment for pancreas, prostate, lung, liver, breast, and oligometastatic cancers, the company said in an Aug. 23 press release.
- The company noted that this is the first hospital in Texas and the third VA hospital to offer MRIdian.
For further details see:
ViewRay MRI-guided radiation therapy selected by VA Houston Healthcare System